A 58-year-old woman with COPD (GOLD Stage 3, FEV₁ 32% predicted) on triple therapy (tiotropium, formoterol, and fluticasone) presents with an acute exacerbation. She has increased sputum purulence, dyspnea, and a 2-day history of fever. Chest X-ray shows no consolidation. She denies hemoptysis. Her current medications are taken correctly via inhaler. What is the most appropriate initial management?

Explanation

## Acute COPD Exacerbation Management ### Clinical Assessment of Severity **Key Point:** This patient has signs of an **acute exacerbation** (increased sputum purulence, dyspnea, fever) but **no indicators of severe/life-threatening disease**: - SpO₂ not mentioned as critically low (assume acceptable on room air) - No respiratory acidosis mentioned - No altered mental status - No signs of cor pulmonale or hemodynamic instability - Chest X-ray shows no consolidation (rules out pneumonia) - Correct inhaler technique confirmed ### GOLD Exacerbation Management Algorithm ```mermaid flowchart TD A[Acute COPD Exacerbation]:::outcome --> B{Severity Assessment}:::decision B -->|Mild-Moderate| C[Outpatient Management]:::action B -->|Severe| D[Hospitalization]:::urgent C --> E[Oral corticosteroids]:::action C --> F[Antibiotics if purulent sputum]:::action C --> G[Short-acting bronchodilators PRN]:::action D --> H[IV corticosteroids]:::action D --> I[Consider ICU if respiratory failure]:::urgent ``` ### Outpatient Management of Mild-to-Moderate Exacerbation | Component | Recommendation | Rationale | |-----------|-----------------|----------| | **Corticosteroids** | Oral prednisolone 30–40 mg daily × 5–7 days | Reduces inflammation, shortens recovery, prevents relapse | | **Antibiotics** | Only if purulent sputum (green/yellow) or signs of infection | This patient has purulent sputum → antibiotic indicated | | **Bronchodilators** | Short-acting β₂-agonist (salbutamol) ± SAMA as needed | Provides rapid symptom relief; continue maintenance therapy | | **Oxygen** | Target SpO₂ 88–92% if hypoxic | Avoid excessive oxygen (CO₂ retention risk) | **High-Yield:** Oral corticosteroids reduce exacerbation duration by ~1 day and reduce treatment failure by ~10%. Antibiotics are indicated only if sputum is purulent or there are signs of bacterial infection. ### Why This Patient Does NOT Require Hospitalization **Clinical Pearl:** Indications for hospitalization include: - Severe dyspnea at rest - Altered mental status - Severe hypoxemia (SpO₂ <88%) or hypercapnia (PaCO₂ >50 mmHg) - Acute respiratory acidosis (pH <7.35) - Hemodynamic instability - Inability to manage at home - Failure of outpatient therapy This patient has **none** of these features. ### Antibiotic Selection for Purulent Exacerbation First-line agents (if indicated): - **Amoxicillin-clavulanate** (oral) - **Fluoroquinolone** (levofloxacin, moxifloxacin) - **Azithromycin** (if macrolide-susceptible organisms) **Mnemonic:** **CURB-65** for pneumonia severity does NOT apply here (no consolidation on CXR), so antibiotics are empirical based on sputum character, not severity scoring. [cite:Harrison 21e Ch 258; GOLD 2023]